By Bhanvi Satija and Khushi Mandowara (Reuters) – AbbVie’s decision to buy Cerevel Therapeutics before key data on the drug developer’s experimental schizophrenia treatment may have helped it avoid a …
Tag:
abbvie’s
-
-
(Reuters) – Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc’s big selling arthritis treatment Humira, adding to U.S. competition for the drug that …
-
(Reuters) – AbbVie Inc’s unit Allergan has reached an agreement to pay over $2 billion to resolve thousands of lawsuits related to the marketing of its opioid painkiller, Bloomberg News …